In particular, activation of IFN-γ response specific for Ag85B, a leading TB vaccine candidate [29], (http://www.clinicaltrials.gov/show/NCT01049282), results in a better control of Mtb infection in numerous experimental animal models [21, 30, 31]. This evidence concerns the gene IFNG and tuberculosis.